OrganiGram posted solid Q1 results OrganiGram (NASDAQ:OGI) reported impressive results for the first quarter of fiscal 2020 on Tuesday. Despite chaos in the cannabis sector, the company reported a positive EBITDA and beat analysts' expectations. OrganiGram has a bright outlook, which instills confidence in investors. Jim Cramer prefers Canopy Growth Although Canopy Growth (NYSE:CGC) struggled in 2019, the stock has gained 14.0% in 2020 as of Tuesday. Jim Cramer, CNBC's Mad Money host, is bullish on Canopy Growth. Investors are optimistic since the company appointed a new CEO, updated its Cannabis 2.0 products, and entered the US CBD market.